Gill Farrar - Concepedia

Author

Gill Farrar

University College London ORCID

Also Known As

Farrar, G, Farrar, Gill, G. E. Farrar, G. Farrar, G.E. Farrar, GILL FARRAR, Gill Farrar

184

Publications

2.7K

Citations

H-Index

Concepts

All Affiliations

University College London Pasqual Maragall Foundation Amsterdam University Medical Centers Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine Barcelonaβeta Brain Research Center

About

Gill Farrar is an author at University College London specializing in medicine, neurology, and alzheimer's disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	6	224
2	Engineering	1	1	12
3	Health Sciences	1	2	60
4	Biochemistry	1	1	13
5	Communicative Disorders	1	2	60

Gill Farrar

Publications

Citations

H-Index

Page 1

	Year	Citations
<sup>18</sup>F‐flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: A phase 2 trial Rik Vandenberghe, Koen Van Laere, Adrian Ivanoiu, Annals of Neurology	2010	636
Post-mortem histopathology underlying β-amyloid PET imaging following flutemetamol F 18 injection Miloš D. Ikonomović, Christopher Buckley, Kerstin Heurling, Acta Neuropathologica Communications	2016	98
Performance of [<sup>18</sup>F]flutemetamol amyloid imaging against the neuritic plaque component of CERAD and the current (2012) NIA‐AA recommendations for the neuropathologic diagnosis of Alzheimer's disease Stephen Salloway, José E. Gámez, Upinder Singh, Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring	2017	91
[18F]Flutemetamol PET imaging and cortical biopsy histopathology for fibrillar amyloid β detection in living subjects with normal pressure hydrocephalus: pooled analysis of four studies Juha O. Rinne, Dean F. Wong, David A. Wolk, Acta Neuropathologica Neuroimaging BiomarkersMedicineNormal Pressure HydrocephalusCortical Biopsy HistopathologyNeuroimaging	2012	81
Defining a Centiloid scale threshold predicting long-term progression to dementia in patients attending the memory clinic: an [18F] flutemetamol amyloid PET study Bernard Hanseeuw, Vincent Malotaux, Laurence Dricot, European Journal of Nuclear Medicine and Molecular Imaging	2020	79
No Association of Lower Hippocampal Volume With Alzheimer’s Disease Pathology in Late-Life Depression François‐Laurent De Winter, Louise Emsell, Filip Bouckaert, American Journal of Psychiatry	2016	77
Quantitative amyloid PET in Alzheimer's disease: the AMYPAD prognostic and natural history study Isadora Lopes Alves, Lyduine E. Collij, Daniele Altomare, Alzheimer s & Dementia	2020	72
Visual assessment of [18F]flutemetamol PET images can detect early amyloid pathology and grade its extent Lyduine E. Collij, Gemma Salvadó, Mahnaz Shekari, European Journal of Nuclear Medicine and Molecular Imaging	2021	64
Pharmacokinetics of [18F]flutemetamol in wild-type rodents and its binding to beta amyloid deposits in a mouse model of Alzheimer’s disease Anniina Snellman, Johanna Rokka, Francisco R. Lopez‐Picon, European Journal of Nuclear Medicine and Molecular Imaging Pharmaceutical ScienceAmyloid DepositsAlzheimer's DiseasePharmacological StudyWild-type Rodents	2012	58
AMYPAD Diagnostic and Patient Management Study: Rationale and design Giovanni B. Frisoni, Frederik Barkhof, Daniele Altomare, Alzheimer s & Dementia	2018	55

Page 1